Type i ifns promote cancer cell stemness by triggering the epigenetic regulator kdm1b

HIGHLIGHTS

• who: Martina Musella from the University of, Milan, Italy have published the research work: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B, in the Journal: (JOURNAL) of 18/04/2021
• what: Putative were also detected in AT3 breast carcinoma namely the CD133+CD44+CD24+low (CD24L ~3.5 times higher compared with the CTR) and CD133+CD44+CD24+high (CD24H ~2.6 times higher compared with the CTR) CSC subsets but the authors focused on the former the widely recognized CSC subpopulation in breast carcinoma19 (Fig 1a). The authors focused . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.